Locally Advanced Disease Clinical Trial Setting

Known as: LOCALLY ADVANCED 
A clinical trial or treatment setting in which the therapy of interest is used to treat locally advanced disease.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND This phase 2 multi-institutional study was designed to determine whether gemcitabine (GEM) with fractionated… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
Review
2015
Review
2015
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Vismodegib, a first-in-class Hedgehog pathway inhibitor, was US Food and Drug Administration (FDA) approved for… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2012
2012
PURPOSE We retrospectively analyzed the results of patients with locally advanced unresectable pancreatic cancer (LAPC) treated… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Background:We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients with locally advanced (LA) or… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE The management of locally advanced (LA) pancreatic cancer patients remains controversial. To select patients who could… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Phase II and III trials of docetaxel, cisplatin and fluorouracil (DCF) have shown superior efficacy versus cisplatin… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2005
2005
PURPOSE To establish the feasibility of capecitabine with concurrent radiotherapy (XRT) in patients with locally advanced (LA… (More)
Is this relevant?
1999
1999
PURPOSE Relapse pattern and late toxicities in long-term survivors were analyzed after the introduction of prophylactic cranial… (More)
Is this relevant?
1993
1993
PURPOSE We compared prospectively the antitumor efficacy of two combination chemotherapy regimens with two different dose levels… (More)
Is this relevant?